Viewing Study NCT00405366


Ignite Creation Date: 2025-12-24 @ 4:35 PM
Ignite Modification Date: 2025-12-29 @ 10:51 PM
Study NCT ID: NCT00405366
Status: COMPLETED
Last Update Posted: 2017-04-18
First Post: 2006-11-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module